|
Status |
Public on Sep 16, 2015 |
Title |
SLM2 control rep 6 |
Sample type |
RNA |
|
|
Source name |
SLM2 control
|
Organism |
Homo sapiens |
Characteristics |
cell line: SLM2 braf status: WT/WT
|
Treatment protocol |
Cells were plated in RPMI + 5% FBS and incubated overnight before being treated with vehicle control in phenol red–free RPMI-1640 without FBS for 8 hours at 37°C.
|
Growth protocol |
Cells are grown in RPMI + 10% FBS and passaged at intervals of 80% confluence.
|
Extracted molecule |
total RNA |
Extraction protocol |
RNA was isolated using the Qiashredder (Qiagen) and RNeasy Mini Kit (Qiagen). RNA was quantified on the NanoDrop 2000 spectrophotometer (Thermo Scientific) and RNA quality was inspected on a 1% agarose gel.
|
Label |
Cy3
|
Label protocol |
Biotin labeled RNA was hybridized to Illumina 3′IVT human HT-12 BeadChip arrays.
|
|
|
Hybridization protocol |
standard as recommended by illumina
|
Scan protocol |
standard as recommended by illumina
|
Description |
Replicate 6
|
Data processing |
VSN By R package lumi
|
|
|
Submission date |
Apr 30, 2015 |
Last update date |
Sep 16, 2015 |
Contact name |
Stefan Bekiranov |
E-mail(s) |
sb3de@virginia.edu
|
Organization name |
University of Virginia
|
Department |
Biochemistry and Molecular Genetics
|
Lab |
Bekiranov Lab
|
Street address |
1340 Jefferson Park Avenue
|
City |
Charlottesville |
State/province |
VA |
ZIP/Postal code |
22903 |
Country |
USA |
|
|
Platform ID |
GPL10558 |
Series (1) |
GSE68453 |
Systems analysis of adaptive responses to MAP Kinase pathway blockade in BRAF mutant melanoma. |
|